Ravisankar Rajarethinam

752 total citations
19 papers, 309 citations indexed

About

Ravisankar Rajarethinam is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Ravisankar Rajarethinam has authored 19 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in Ravisankar Rajarethinam's work include Mosquito-borne diseases and control (6 papers), Viral Infections and Vectors (5 papers) and Immune Cell Function and Interaction (4 papers). Ravisankar Rajarethinam is often cited by papers focused on Mosquito-borne diseases and control (6 papers), Viral Infections and Vectors (5 papers) and Immune Cell Function and Interaction (4 papers). Ravisankar Rajarethinam collaborates with scholars based in Singapore, United Kingdom and United States. Ravisankar Rajarethinam's co-authors include Teck‐Hui Teo, Lisa F. P. Ng, Fok‐Moon Lum, Siti Naqiah Amrun, Laurent Rénia, Yi‐Hao Chan, Wendy W. L. Lee, Andres Merits, Zhisheng Her and Olaf Rötzschke and has published in prestigious journals such as Nature Communications, Nature Cell Biology and Oncogene.

In The Last Decade

Ravisankar Rajarethinam

18 papers receiving 304 citations

Peers

Countries citing papers authored by Ravisankar Rajarethinam

Since Specialization

Citations

This map shows the geographic impact of Ravisankar Rajarethinam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravisankar Rajarethinam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravisankar Rajarethinam more than expected).

Fields of papers citing papers by Ravisankar Rajarethinam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravisankar Rajarethinam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravisankar Rajarethinam. The network helps show where Ravisankar Rajarethinam may publish in the future.

Co-authorship network of co-authors of Ravisankar Rajarethinam

This figure shows the co-authorship network connecting the top 25 collaborators of Ravisankar Rajarethinam. A scholar is included among the top collaborators of Ravisankar Rajarethinam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravisankar Rajarethinam. Ravisankar Rajarethinam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	LRG1 inhibition promotes acute pancreatitis recovery by inducing cholecystokinin Type 1 receptor expression via Akt 2025 ·Theranostics ·(unknown), (unknown), Shuqing Liu, Wenjuan Zhang, (unknown), Nidula Mullappilly, Sandip M. Swain, (unknown), Ravisankar Rajarethinam, Kah Fei Wan, Christiane Ruedl, Rodger A. Liddle, Liang Li, Xiaomeng Wang	0
2	B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors 2024 ·Cancer Research Communications ·Siok Ping Yeo, Lindsay Kua, (unknown), (unknown), (unknown), (unknown), Chek Meng Poh, Anthony T.C. Goh, (unknown), (unknown), Ravisankar Rajarethinam, Qingfeng Chen, Zhisheng Her, Ivan D. Horak, Lionel Low, Kar Wai Tan	3
3	Differential mucosal tropism and dissemination of classical and hypervirulent Klebsiella pneumoniae infection 2024 ·iScience ·Teck‐Hui Teo, (unknown), (unknown), (unknown), (unknown), Natalia Kurepina, Ravisankar Rajarethinam, Barry N. Kreiswirth, Liang Chen, Pablo Bifani	8
4	Fetal liver CD34+ contain human immune and endothelial progenitors and mediate solid tumor rejection in NOG mice 2024 ·Stem Cell Research & Therapy ·Teja Celhar, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ravisankar Rajarethinam, Yiping Fan, Anselm Mak, Jerry Kok Yen Chan, Amit Singhal, Takeshi Takahashi	1
5	Color changing bioadhesive barrier for peripherally inserted central catheters 2024 ·Biomaterials Science ·Ivan Djordjevic, (unknown), Juhi Singh, (unknown), Edgar M. Peña-Galo, Ravisankar Rajarethinam, Manikandan Lakshmanan, Jason Goh, Sierin Lim, Terry W. J. Steele	1
6	CENTRAL NERVOUS SYSTEM TUBERCULOSIS IMMUNOPATHOLOGY IS DRIVEN BY MATRIX DESTRUCTION WITH MATRIX METALLOPROTEINASES INHIBITION REDUCING INFLAMMATION AND IMPROVING SURVIVAL 2023 ·International Journal of Infectious Diseases ·(unknown), (unknown), Chenjun Bai, Ji‐Man Hong, Qing Hao Miow, Heng Thay Chong, (unknown), Yang Wang, (unknown), (unknown), Siew Moy Fong, (unknown), Ravisankar Rajarethinam, (unknown), (unknown), C. C. Tchoyoson Lim, Tsin Wen Yeo, Ong C	1
7	CD8+ T Cells Trigger Auricular Dermatitis and Blepharitis in Mice after Zika Virus Infection in the Absence of CD4+ T Cells 2022 ·Journal of Investigative Dermatology ·Cheryl Yi‐Pin Lee, Guillaume Carissimo, Teck‐Hui Teo, (unknown), Zi Wei Chang, Ravisankar Rajarethinam, (unknown), (unknown), Rhonda Sin‐Ling Chee, Alicia Tay, Shanshan Wu Howland, Kok Siong Ang, Jinmiao Chen, Laurent Rénia, Lisa F. P. Ng	3
8	Nos2−/− mice infected with M. tuberculosis develop neurobehavioral changes and immunopathology mimicking human central nervous system tuberculosis 2022 ·Journal of Neuroinflammation ·(unknown), (unknown), Chen Bai, Qing Hao Miow, Pei Min Thong, Yu Wang, Ravisankar Rajarethinam, (unknown), Ong C	5
9	Successful targeting of PD-1/PD-L1 with chimeric antigen receptor-natural killer cells and nivolumab in a humanized mouse cancer model 2022 ·Science Advances ·(unknown), Wing Yan So, (unknown), (unknown), (unknown), Wilson Wei Sheng Tan, Sue Yee Tan, (unknown), Ravisankar Rajarethinam, Min Liu, (unknown), Lisda Suteja, Joe Yeong, N. Gopalakrishna Iyer, Wan‐Teck Lim, Qingfeng Chen	32
10	Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells 2021 ·Molecular Cancer Therapeutics ·(unknown), Zhiyong Ye, Alice M.S. Cheung, Yufen Goh, Hsueh Ling Janice Oh, Ravisankar Rajarethinam, Siok Ping Yeo, (unknown), Esther Hian Li Chan, Lip Kun Tan, Soo‐Yong Tan, Charles Chuah, Wee Joo Chng, John E. Connolly, (unknown)	37
11	A mouse model of lethal respiratory dysfunction for SARS-CoV-2 infection 2021 ·Antiviral Research ·Esther S. Gan, Ayesa Syenina, Martin Linster, (unknown), Summer L. Zhang, Satoru Watanabe, Ravisankar Rajarethinam, Hwee Cheng Tan, Gavin J. D. Smith, Eng Eong Ooi	8
12	A tumour-resident Lgr5+ stem-cell-like pool drives the establishment and progression of advanced gastric cancers 2021 ·Nature Cell Biology ·Aliya Fatehullah, Yumi Terakado, (unknown), (unknown), (unknown), Shawna Tan, Kazuhiro Murakami, Swathi Yada, Nicholas Ang, Ravisankar Rajarethinam, (unknown), Patrick Tan, Bob S. L. Lee, Nick Barker	52
13	Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection 2020 ·Frontiers in Immunology ·Yi‐Hao Chan, Teck‐Hui Teo, Anthony Torres‐Ruesta, Siddesh V. Hartimath, Rhonda Sin‐Ling Chee, Shivashankar Khanapur, Fui‐Fong Yong, Boominathan Ramasamy, (unknown), Ravisankar Rajarethinam, Edward G. Robins, Julian Goggi, Fok‐Moon Lum, Guillaume Carissimo, Laurent Rénia, Lisa F. P. Ng	9
14	Type I interferon shapes the quantity and quality of the anti‐Zika virus antibody response 2020 ·Clinical & Translational Immunology ·Cheryl Yi‐Pin Lee, Guillaume Carissimo, (unknown), Fok‐Moon Lum, (unknown), Ravisankar Rajarethinam, Teck‐Hui Teo, Anthony Torres‐Ruesta, Laurent Rénia, Lisa F. P. Ng	7
15	Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate 2019 ·EMBO Molecular Medicine ·Yi‐Hao Chan, Teck‐Hui Teo, Age Utt, Jeslin J. L. Tan, Siti Naqiah Amrun, (unknown), (unknown), Étienne Becht, Cheryl Yi‐Pin Lee, Bernett Lee, Ravisankar Rajarethinam, Evan W. Newell, Andres Merits, Guillaume Carissimo, Fok‐Moon Lum, Lisa F. P. Ng	21
16	Plasmodium co-infection protects against chikungunya virus-induced pathologies 2018 ·Nature Communications ·Teck‐Hui Teo, Fok‐Moon Lum, Khairunnisa Abdul Ghaffar, Yi‐Hao Chan, Siti Naqiah Amrun, Jeslin J. L. Tan, Cheryl Yi‐Pin Lee, (unknown), Guillaume Carissimo, Wendy W. L. Lee, Carla Claser, Ravisankar Rajarethinam, Laurent Rénia, Lisa F. P. Ng	26
17	GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers 2017 ·Oncogene ·Suhail Ahmed Kabeer Rasheed, Hui Sun Leong, Manikandan Lakshmanan, Anandhkumar Raju, (unknown), (unknown), Nicholas B. Shannon, Ravisankar Rajarethinam, Thakshayeni Skanthakumar, Ern Yu Tan, Jacqueline Siok Gek Hwang, (unknown), Daniel Shao-Weng Tan, Paolo Ceppi, Mei Wang, Vinay Tergaonkar, Patrick J. Casey, N. Gopalakrishna Iyer	33
18	Fingolimod treatment abrogates chikungunya virus–induced arthralgia 2017 ·Science Translational Medicine ·Teck‐Hui Teo, Yi‐Hao Chan, Wendy W. L. Lee, Fok‐Moon Lum, Siti Naqiah Amrun, Zhisheng Her, Ravisankar Rajarethinam, Andres Merits, Olaf Rötzschke, Laurent Rénia, Lisa F. P. Ng	50
19	Volume of the pineal gland in schizophrenia; an MRI study 1995 ·Schizophrenia Research ·Ravisankar Rajarethinam	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact